查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1988215

胃束帶市場：2026-2032年全球市場預測（依產品類型、年齡層、性別、通路和最終用戶分類）

Gastric Bands Market by Product Type, Age Group, Gender, Distribution Channel, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，胃束帶市場價值將達到 6,917 萬美元，到 2026 年將成長到 7,867 萬美元，到 2032 年將達到 9,818 萬美元，複合年成長率為 5.12%。

主要市場統計數據
基準年 2025 6917萬美元
預計年份：2026年 7867萬美元
預測年份 2032 9818萬美元
複合年成長率 (%) 5.12%

現代胃束帶療法和決策受到臨床實踐變化、設備改進以及對相關人員期望的清晰務實觀點。

胃束帶療法的現狀正處於臨床實用性、器械工程和不斷變化的患者期​​望三者交匯之處。胃束帶療法傳統上被視為一種微創手術減重方案，近年來，隨著植入設計、生理食鹽水填充最佳化和手術全期期方案的不斷改進，該通訊協定也持續改進。這些改進影響了臨床決策、患者選擇標準以及多學科診療路徑的作用。因此，相關人員現在不僅從臨床結果的角度評估胃束帶療法的應用，還從手術效率、病患滿意度指標和器械生命週期管理等方面進行考慮。

技術創新、不斷發展的護理路徑、監管要求和患者行為正在重塑胃束帶解決方案的部署和價值交付。

胃束帶領域的變革性變化反映了技術進步、醫療服務模式轉變以及患者偏好變化的同步發展。器械創新主要集中在可調節系統上，以實現內部限制，其中基於生理鹽水的調節方式尤其受到尋求可預測且可逐步調整治療效果的臨床醫生的青睞。端口設計、生理食鹽水材質和腹腔鏡植入技術的創新也減輕了手術負擔，並提高了圍手術全期安全性。因此，手術團隊正在調整工作流程，以適應術後反覆調整和加強病患教育。

2025 年美國關稅調整對醫療設備利害關係人的營運和商業影響，包括重組到岸成本、籌資策略和供應鏈韌性。

2025年美國關稅政策的變化為醫療設備供應鏈帶來了重大的物流和商業性挑戰，包括胃束帶組件和配件的相關問題。進口關稅和海關程序的調整影響了接收成本，並促使供應商和醫療採購方在成本分配方面提高透明度。因此，採購團隊和經銷商越來越重視透明的總擁有成本（TCO）對話，不僅考慮單價，還考慮出貨頻率、庫存管理和退貨流量等因素。

這項研究著重於胃束帶療法的細分，將產品設計、分銷管道、臨床環境和人口統計群體聯繫起來，以指導可行的商業化策略。

對市場區隔的精準理解揭示了臨床效用、分銷動態和患者人口統計特徵之間的交集，從而影響產品策略和商業化計劃。根據產品類型，醫療器材可分為可調節型和不可調節型。可調節系統，特別是那些配備生理食鹽水填充調節機制、允許術後調節和患者個別化管理的系統，是研究的熱點。這種差異會影響臨床訓練需求、追蹤頻率以及器材的售後服務。

針對美洲、歐洲、中東和非洲以及亞太地區的採購實務、監管複雜性、臨床訓練系統和病患期望，提供區域性見解。

地理環境塑造了世界各大區域不同的臨床實務模式、監管路徑、分銷物流以及病患期望。在美洲，醫療採購往往集中在大規模醫院系統和專科醫療網路中，這些機構強調標準化的採購通訊協定、整合的診療路徑以及整合的供應商關係。這種環境有利於那些擁有完善的醫療設備培訓項目、高效的協調工作流程以及明確的服務承諾的醫療器械，從而最大限度地減少長期追蹤中的差異。

競爭與合作的動態，強調產品可靠性、臨床醫生教育、卓越的售後服務和綜合護理夥伴關係，塑造了行業領導地位。

胃束帶市場企業的競爭動態受產品工程、臨床證據的累積、監管策略以及售後支援服務能力的影響。主要企業將迭代式設備改進與全面的臨床醫生教育計畫和快速的售後服務相結合，使外科團隊能夠自信地採用適應性強的系統。透過註冊登記和長期追蹤研究證明設備性能的穩定性，有助於增強臨床醫生的信心，並促使醫療機構優先採購。

為促進永續採用，提出切實可行的建議，將產品創新、臨床醫生教育、有韌性的分銷網路和證據生成聯繫起來。

產業領導企業應優先考慮協作策略，將產品創新、臨床應用和分銷管道的韌性相結合，以確保臨床應用的永續。首先，應投資改進設備設計，簡化手術全期操作和術後調整，同時制定標準化的臨床醫生培訓課程，以減少治療結果的差異，並支持技能的快速傳播。標準化通訊協定將有助於順利融入醫院和門診工作流程，並加強醫保報銷談判。

為了得出基於證據的結論，我們採用了嚴謹的混合方法研究途徑，結合了對臨床醫生的訪談、監管和文獻分析、來自分銷商的資訊以及專家評論。

本研究採用結構化、多方面的方法整合了一手和二手資訊，旨在確保研究的嚴謹性和透明度。一手資訊包括對外科醫生、門診中心主任、採購負責人、分銷商高管和臨床主任的訪談，以了解他們對器械操作、調整流程和採購考慮的實際觀點。除這些定性訪談外，本研究還對同行評審的臨床文獻、監管申報文件和器械安全資訊揭露進行了系統性回顧，以檢驗技術聲明並識別新出現的安全徵兆。

策略整合確定了決定胃束帶解決方案永續部署的核心優先事項—臨床價值、分銷韌性、證據產生和上市後支援。

總之，目前胃束帶技術的特點是器械設計日益精密、臨床路徑不斷發展，並且越來越重視上市後證據和供應鏈的韌性。可調節的生理食鹽水填充系統仍然是劑量可調治療方法和長期患者管理討論的核心，但其成功不僅取決於器械的功能，還高度依賴於臨床醫生的培訓、便捷的隨訪以及靈活的配送。監管機構的期望和支付方的審查使得在採購考量中，可證實的安全性和以病人為中心的療效指標的重要性日益凸顯。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：胃束帶市場：依產品類型分類

  • 可調節的
  • 不可調節

第9章：胃束帶市場：依年齡層別分類

  • 成人版
    • 18-35歲
    • 36-50歲
    • 51歲或以上
  • 兒童

第10章：胃束帶市場：性別

  • 女士
  • 男性

第11章：胃束帶市場：依通路分類

  • 直銷
  • 銷售代理
    • 線上管道
      • 電子商務平台
      • 製造商網站
    • 第三方經銷商

第12章：胃束帶市場：依最終用戶分類

  • 門診手術中心
  • 診所
  • 醫院

第13章：胃束帶市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：胃束帶市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：胃束帶市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國胃束帶市場

第17章：中國胃束帶市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Allergan plc
  • Apollo Endosurgery, Inc.
  • Cousin Biotech SAS
  • Endo Tools Therapeutics SA
  • EndoGastric Solutions, Inc.
  • Ethicon Endo-Surgery, LLC
  • Hangzhou Kangning Medical Instruments Co., Ltd.
  • Hologic, Inc.
  • JOHNSON & JOHNSON SERVICES, INC.
  • Karl Storz SE & Co. KG
  • Mediflex Surgical Products
  • Medline Industries, LP
  • Medtronic Plc
  • New York Bariatric Group's
  • Obtech Medical AG
  • ReShape Lifesciences Inc.
  • SILIMED INDUSTRIA DE IMPANTES LTDA
  • Spatz FGIA Inc.
  • Surgical Tools, Inc.
  • TedPella Inc.
  • USGI Medical
  • WL Gore & Associates, Inc.
Product Code: MRR-8E373E9E21A8

The Gastric Bands Market was valued at USD 69.17 million in 2025 and is projected to grow to USD 78.67 million in 2026, with a CAGR of 5.12%, reaching USD 98.18 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 69.17 million
Estimated Year [2026] USD 78.67 million
Forecast Year [2032] USD 98.18 million
CAGR (%) 5.12%

A clear and pragmatic orientation to clinical practice shifts, device refinement, and stakeholder expectations framing contemporary gastric band therapy and decision-making

The landscape of gastric band therapy sits at the intersection of clinical pragmatism, device engineering, and evolving patient expectations. Historically positioned as a less invasive surgical option for weight management, gastric band solutions have been continuously refined through advances in implant design, saline fill optimization, and perioperative protocols. These refinements have influenced clinical decision-making, patient selection criteria, and the role of multidisciplinary care pathways. Consequently, stakeholders now evaluate gastric band adoption not only through clinical outcomes but also through procedural efficiency, patient satisfaction metrics, and lifecycle management of the device.

Emerging evidence and practice patterns have prompted clinicians to reassess indications and long-term management strategies, while manufacturers prioritize device reliability, ease of adjustment, and compatibility with minimally invasive techniques. At the same time, payors and institutional purchasers increasingly require robust evidence of safety, consistent follow-up protocols, and demonstrable improvements in patient-reported outcomes. Therefore, an effective introduction to this sector must encompass the converging perspectives of surgeons, interventional clinicians, patients, and procurement specialists, framing gastric bands as one component within a broader continuum of metabolic and bariatric care.

This report's introduction situates gastric band therapy within this complex ecosystem, clarifying clinical pathways, supply considerations, and the strategic trade-offs faced by hospitals, clinics, and ambulatory centers. By synthesizing device-level developments with care delivery realities, readers will gain a pragmatic foundation for the deeper analyses that follow.

How technological innovations, evolving care pathways, regulatory expectations, and patient behavior together are reshaping adoption and value delivery for gastric band solutions

Transformative shifts in the gastric band landscape reflect simultaneous advances in technology, shifts in care delivery models, and changing patient preferences. Device innovations have focused on adjustable systems that permit in situ modulation of restriction, with saline-filled adjustability becoming a focal point for clinicians seeking predictable, titratable outcomes. Innovations in port design, tubing materials, and laparoscopic deployment techniques have also reduced procedural friction and improved perioperative safety profiles. Consequently, surgical teams have adapted workflows to accommodate iterative postoperative adjustments and extended patient education initiatives.

Parallel to device evolution, distribution and purchasing behaviors are changing as health systems pursue supply chain resilience and cost transparency. Digital engagement channels now influence both clinician procurement and patient education, supporting more informed device selection and follow-up adherence. At the same time, regulatory scrutiny and clinical evidence requirements have intensified, prompting manufacturers to invest in postmarket surveillance and real-world evidence generation. These investments are reshaping how clinical value is demonstrated and how reimbursement conversations are framed.

Finally, demographic and lifestyle trends are altering the patient mix that clinicians encounter, which in turn influences device selection and follow-up protocols. Taken together, these transformative shifts require coordinated responses across R&D, clinical affairs, and commercial functions to translate innovation into durable clinical adoption and sustained patient benefit.

Operational and commercial implications of the 2025 U.S. tariff adjustments that reshaped landed costs, procurement strategies, and supply chain resilience for device stakeholders

Tariff policy developments in the United States during 2025 introduced notable logistical and commercial considerations for medical device supply chains, including those relevant to gastric band components and ancillary materials. Adjustments in import duties and customs procedures have influenced landed costs and created a need for clearer cost allocation between suppliers and institutional purchasers. As a result, procurement teams and distributors have increasingly prioritized transparent total-cost-of-ownership conversations, considering not only unit price but also shipment frequency, inventory management, and return logistics.

Operationally, manufacturers and distributors have responded by reassessing sourcing strategies, diversifying supplier bases, and evaluating regional warehousing alternatives to mitigate tariff exposure. Longer-term contractual arrangements with distributors and direct sales agreements have been renegotiated to reflect shifting cost structures, while some suppliers have explored partial localization of assembly or packaging activities to preserve competitiveness. These adaptations have emphasized supply chain agility, with an emphasis on predictable lead times and clear commercial terms.

Clinicians and hospital administrators have also been affected indirectly through procurement timelines and contracting cycles. To navigate the 2025 tariff-related disruptions, stakeholders prioritized transparent supplier communication, contingency inventory planning, and collaborative forecast sharing between device manufacturers and major institutional buyers. In aggregate, the tariff environment acted as a catalyst for supply-chain modernization, pushing stakeholders toward resilient operational models that reduce vulnerability to future policy shifts.

Segmentation-focused insights that tie product design, distribution channels, clinical settings, and demographic cohorts into actionable commercialization strategies for gastric band therapies

A nuanced understanding of segmentation illuminates where clinical utility, distribution dynamics, and patient demographics intersect to influence product strategy and commercialization planning. Based on product type, devices fall into adjustable and non-adjustable categories, with adjustable systems frequently studied for their saline-filled adjustment mechanism that allows postoperative titration and tailored patient management. This differentiation affects clinical training requirements, follow-up cadence, and device service offerings.

Based on distribution channel, sales flow through direct sales relationships and distributor networks, where distributors commonly operate via online channels and third party distributors. Within online channels, e-commerce platforms and manufacturer websites serve distinct roles: e-commerce platforms aggregate options for institutional and clinic buyers, while manufacturer websites provide product education, technical documentation, and direct ordering capabilities. These chained distribution structures influence pricing transparency, inventory visibility, and the speed at which new product iterations are adopted by clinical end users.

Based on end user, gastric band procedures are performed across ambulatory surgical centers, clinics, and hospitals, each with different procedural volumes, staffing models, and reimbursement interactions. Based on age group, the patient mix comprises adult and pediatric populations, with adult cohorts further segmented into 18-35, 36-50, and 51 plus age bands that reflect varied comorbidity profiles and lifestyle considerations. Based on gender, devices are used across female and male populations, and device design and counseling approaches must account for gender-specific outcomes, body composition differences, and patient preferences. Integrating these segmentation lenses enables targeted product messaging, tailored training programs, and optimized distribution strategies aligned with the realities of clinical practice.

Region-specific intelligence connecting procurement behavior, regulatory complexity, clinical training infrastructure, and patient expectations across the Americas, EMEA, and Asia-Pacific

Geographic context shapes clinical practice patterns, regulatory pathways, distribution logistics, and patient expectations in distinct ways across the world's principal regions. In the Americas, institutional purchasing tends to concentrate with large hospital systems and specialty networks that emphasize standardized procurement protocols, integrated care pathways, and consolidated vendor relationships. This environment favors devices supported by strong clinical training programs, efficient adjustment workflows, and clear service commitments to minimize variability in long-term follow-up.

In Europe, Middle East & Africa, the regulatory mosaic and reimbursement heterogeneity require flexible entry strategies that account for country-level reimbursement mechanisms and varied clinical infrastructure. Adoption in these territories is often influenced by national guideline endorsements, clinician networks that cross-border training programs, and distributor partnerships capable of navigating local logistics and regulatory requirements. Companies that invest in local evidence generation and clinician education generally find better uptake across diverse health systems.

In Asia-Pacific, rapid clinical capacity expansion and growing investment in minimally invasive surgical techniques create opportunities for devices that can be deployed with scalable training and support models. Distribution strategies in the region often combine direct sales in mature urban centers with distributor-led approaches in emerging markets. Moreover, patient preferences and demographic trends in Asia-Pacific emphasize early intervention and technology-enabled follow-up, which in turn influence product design priorities and aftercare service offerings. Across all regions, aligning regulatory, clinical, and commercial plans to regional characteristics is essential for sustainable adoption.

Competitive and partnership dynamics emphasizing product reliability, clinician education, aftermarket service excellence, and integrated care partnerships shaping sector leadership

Competitive dynamics among firms active in the gastric band space are shaped by capabilities in product engineering, clinical evidence generation, regulatory strategy, and postmarket support services. Leading companies combine iterative device improvements with robust clinician education programs and responsive aftermarket services, enabling surgical teams to adopt adjustable systems with confidence. The ability to demonstrate consistent device performance through registries and long-term follow-up contributes to clinician trust and institutional procurement favorability.

Strategically, some firms emphasize narrow product portfolios with depth in implant quality and procedural support, while others pursue broader portfolios that bundle related bariatric tools and consumables to capture more of the perioperative value chain. Distribution partnerships remain a core differentiator; companies that maintain both direct sales presence in key urban markets and agile distributor networks in more fragmented territories achieve greater coverage and responsiveness. In addition, investment in digital tools for patient engagement and remote follow-up enhances aftercare adherence and provides real-world data that can inform iterative product refinements.

From an M&A and partnership perspective, alliances between device innovators, surgical services providers, and digital health firms are increasingly common as companies seek to integrate device performance with care pathways and remote monitoring capabilities. Overall, firms that align product reliability, clinician training, evidence generation, and customer-centric service emerge as preferred partners for healthcare organizations implementing gastric band programs.

Practical and high-impact recommendations for aligning product innovation, clinician education, resilient distribution, and evidence generation to drive durable adoption

Industry leaders should prioritize a coordinated strategy that aligns product innovation, clinical engagement, and distribution resilience to secure sustainable clinical adoption. First, invest in device design enhancements that simplify perioperative handling and postoperative adjustment, while concurrently developing standardized clinician training curricula that reduce variability in outcomes and support rapid skill dissemination. Standardized protocols will facilitate smoother integration into hospital and ambulatory workflows and strengthen reimbursement discussions.

Second, build distribution strategies that balance direct sales presence in major markets with selective distributor partnerships in fragmented territories, complemented by regional warehousing to mitigate tariff and logistics disruptions. This hybrid approach enhances responsiveness while preserving cost efficiency. Third, accelerate evidence generation through registries and structured postmarket studies that capture patient-reported outcomes and long-term device performance, enabling sales and clinical affairs teams to address hesitations with empirical data.

Fourth, deploy digital patient engagement and remote monitoring solutions to enhance aftercare adherence and collect real-world insights that can inform iterative device improvements. Finally, pursue targeted collaborations-whether clinical, academic, or technological-to broaden the value proposition and demonstrate comprehensive care solutions. By operationalizing these priorities, leaders will enhance clinical trust, streamline procurement processes, and position their offerings for durable integration into multidisciplinary care pathways.

A rigorous mixed-methods research approach blending clinician interviews, regulatory and literature analysis, distributor intelligence, and expert review to ensure evidence-based conclusions

This research synthesized primary and secondary intelligence through a structured, multi-source approach designed to ensure rigor and transparency. Primary inputs included interviews with surgeons, ambulatory center directors, procurement professionals, distributor executives, and clinical affairs leaders to capture frontline perspectives on device handling, adjustment workflows, and purchasing considerations. These qualitative discussions were complemented by a systematic review of peer-reviewed clinical literature, regulatory filings, and device safety bulletins to validate technical claims and identify emerging safety signals.

Secondary inputs encompassed company product literature, procedural training materials, and publicly available guidelines that contextualize clinical practice patterns. Data validation comprised cross-referencing interview findings with published clinical outcomes and device performance reports, followed by triangulation across multiple stakeholders to reconcile divergent viewpoints. In addition, geographic analyses integrated inputs from regional distribution partners and health system procurement officers to map regulatory and logistical constraints.

Finally, methodological safeguards included independent expert review of clinical interpretations and a documented audit trail for source attribution. While proprietary commercial terms and contract-level pricing were not disclosed, the methodology prioritized transparency, reproducibility, and stakeholder balance to produce insights that are both robust and operationally relevant.

A strategic synthesis identifying core priorities-clinical value, distribution resilience, evidence generation, and postmarket support-that determine durable adoption of gastric band solutions

In conclusion, the contemporary gastric band landscape is characterized by refined device engineering, evolving clinical pathways, and an increasing emphasis on postmarket evidence and supply chain resilience. Adjustable, saline-filled systems remain central to discussions about titratable therapy and long-term patient management, but successful adoption depends as much on clinician training, accessible follow-up, and distribution agility as on device features alone. Regulatory expectations and payer scrutiny have elevated the importance of demonstrable safety and patient-centered outcomes in procurement deliberations.

Operational challenges-exemplified by tariff-induced logistics adjustments-have highlighted the need for diversified sourcing and transparent procurement practices. Regionally, differentiated strategies that respect local regulatory frameworks, reimbursement environments, and clinical infrastructure will be essential for sustained deployment. Finally, companies that integrate reliable products with comprehensive clinician education, digital aftercare tools, and robust real-world evidence programs will be best positioned to meet the needs of healthcare providers and patients alike.

Collectively, these conclusions point toward a pragmatic path forward: prioritize tangible clinical value, reinforce distribution and service capabilities, and invest in evidence generation that supports confident clinical and institutional adoption.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Gastric Bands Market, by Product Type

  • 8.1. Adjustable
  • 8.2. Non Adjustable

9. Gastric Bands Market, by Age Group

  • 9.1. Adult
    • 9.1.1. 18-35
    • 9.1.2. 36-50
    • 9.1.3. 51 Plus
  • 9.2. Pediatric

10. Gastric Bands Market, by Gender

  • 10.1. Female
  • 10.2. Male

11. Gastric Bands Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. Distributors
    • 11.2.1. Online Channels
      • 11.2.1.1. E Commerce Platforms
      • 11.2.1.2. Manufacturer Website
    • 11.2.2. Third Party Distributors

12. Gastric Bands Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Clinics
  • 12.3. Hospitals

13. Gastric Bands Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Gastric Bands Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Gastric Bands Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Gastric Bands Market

17. China Gastric Bands Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Allergan plc
  • 18.6. Apollo Endosurgery, Inc.
  • 18.7. Cousin Biotech SAS
  • 18.8. Endo Tools Therapeutics S.A.
  • 18.9. EndoGastric Solutions, Inc.
  • 18.10. Ethicon Endo-Surgery, LLC
  • 18.11. Hangzhou Kangning Medical Instruments Co., Ltd.
  • 18.12. Hologic, Inc.
  • 18.13. JOHNSON & JOHNSON SERVICES, INC.
  • 18.14. Karl Storz SE & Co. KG
  • 18.15. Mediflex Surgical Products
  • 18.16. Medline Industries, LP
  • 18.17. Medtronic Plc
  • 18.18. New York Bariatric Group's
  • 18.19. Obtech Medical AG
  • 18.20. ReShape Lifesciences Inc.
  • 18.21. SILIMED INDUSTRIA DE IMPANTES LTDA
  • 18.22. Spatz FGIA Inc.
  • 18.23. Surgical Tools, Inc.
  • 18.24. TedPella Inc.
  • 18.25. USGI Medical
  • 18.26. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL GASTRIC BANDS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL GASTRIC BANDS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL GASTRIC BANDS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL GASTRIC BANDS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL GASTRIC BANDS MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL GASTRIC BANDS MARKET SIZE, BY GENDER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL GASTRIC BANDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL GASTRIC BANDS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL GASTRIC BANDS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GASTRIC BANDS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL GASTRIC BANDS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES GASTRIC BANDS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA GASTRIC BANDS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL GASTRIC BANDS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL GASTRIC BANDS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL GASTRIC BANDS MARKET SIZE, BY ADJUSTABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL GASTRIC BANDS MARKET SIZE, BY ADJUSTABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL GASTRIC BANDS MARKET SIZE, BY ADJUSTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL GASTRIC BANDS MARKET SIZE, BY NON ADJUSTABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL GASTRIC BANDS MARKET SIZE, BY NON ADJUSTABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL GASTRIC BANDS MARKET SIZE, BY NON ADJUSTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL GASTRIC BANDS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL GASTRIC BANDS MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL GASTRIC BANDS MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL GASTRIC BANDS MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL GASTRIC BANDS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL GASTRIC BANDS MARKET SIZE, BY 18-35, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL GASTRIC BANDS MARKET SIZE, BY 18-35, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL GASTRIC BANDS MARKET SIZE, BY 18-35, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL GASTRIC BANDS MARKET SIZE, BY 36-50, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL GASTRIC BANDS MARKET SIZE, BY 36-50, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL GASTRIC BANDS MARKET SIZE, BY 36-50, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL GASTRIC BANDS MARKET SIZE, BY 51 PLUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL GASTRIC BANDS MARKET SIZE, BY 51 PLUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL GASTRIC BANDS MARKET SIZE, BY 51 PLUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL GASTRIC BANDS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL GASTRIC BANDS MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL GASTRIC BANDS MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL GASTRIC BANDS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL GASTRIC BANDS MARKET SIZE, BY FEMALE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL GASTRIC BANDS MARKET SIZE, BY FEMALE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL GASTRIC BANDS MARKET SIZE, BY FEMALE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL GASTRIC BANDS MARKET SIZE, BY MALE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL GASTRIC BANDS MARKET SIZE, BY MALE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL GASTRIC BANDS MARKET SIZE, BY MALE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL GASTRIC BANDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL GASTRIC BANDS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL GASTRIC BANDS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL GASTRIC BANDS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL GASTRIC BANDS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL GASTRIC BANDS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL GASTRIC BANDS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL GASTRIC BANDS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL GASTRIC BANDS MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL GASTRIC BANDS MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL GASTRIC BANDS MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL GASTRIC BANDS MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL GASTRIC BANDS MARKET SIZE, BY E COMMERCE PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL GASTRIC BANDS MARKET SIZE, BY E COMMERCE PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL GASTRIC BANDS MARKET SIZE, BY E COMMERCE PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL GASTRIC BANDS MARKET SIZE, BY MANUFACTURER WEBSITE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL GASTRIC BANDS MARKET SIZE, BY MANUFACTURER WEBSITE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL GASTRIC BANDS MARKET SIZE, BY MANUFACTURER WEBSITE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL GASTRIC BANDS MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL GASTRIC BANDS MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL GASTRIC BANDS MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL GASTRIC BANDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL GASTRIC BANDS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL GASTRIC BANDS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL GASTRIC BANDS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL GASTRIC BANDS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL GASTRIC BANDS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL GASTRIC BANDS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL GASTRIC BANDS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL GASTRIC BANDS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL GASTRIC BANDS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL GASTRIC BANDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS GASTRIC BANDS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS GASTRIC BANDS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS GASTRIC BANDS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS GASTRIC BANDS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS GASTRIC BANDS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS GASTRIC BANDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS GASTRIC BANDS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS GASTRIC BANDS MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS GASTRIC BANDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA GASTRIC BANDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA GASTRIC BANDS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA GASTRIC BANDS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA GASTRIC BANDS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA GASTRIC BANDS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA GASTRIC BANDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA GASTRIC BANDS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA GASTRIC BANDS MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA GASTRIC BANDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA GASTRIC BANDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA GASTRIC BANDS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA GASTRIC BANDS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA GASTRIC BANDS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA GASTRIC BANDS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA GASTRIC BANDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA GASTRIC BANDS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA GASTRIC BANDS MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA GASTRIC BANDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA GASTRIC BANDS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA GASTRIC BANDS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA GASTRIC BANDS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA GASTRIC BANDS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA GASTRIC BANDS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA GASTRIC BANDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA GASTRIC BANDS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA GASTRIC BANDS MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA GASTRIC BANDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE GASTRIC BANDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE GASTRIC BANDS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE GASTRIC BANDS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE GASTRIC BANDS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE GASTRIC BANDS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE GASTRIC BANDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE GASTRIC BANDS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE GASTRIC BANDS MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE GASTRIC BANDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST GASTRIC BANDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST GASTRIC BANDS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST GASTRIC BANDS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST GASTRIC BANDS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST GASTRIC BANDS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST GASTRIC BANDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST GASTRIC BANDS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST GASTRIC BANDS MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST GASTRIC BANDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA GASTRIC BANDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA GASTRIC BANDS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA GASTRIC BANDS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA GASTRIC BANDS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA GASTRIC BANDS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA GASTRIC BANDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA GASTRIC BANDS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA GASTRIC BANDS MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA GASTRIC BANDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC GASTRIC BANDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC GASTRIC BANDS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC GASTRIC BANDS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC GASTRIC BANDS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC GASTRIC BANDS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC GASTRIC BANDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC GASTRIC BANDS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC GASTRIC BANDS MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC GASTRIC BANDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL GASTRIC BANDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN GASTRIC BANDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN GASTRIC BANDS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN GASTRIC BANDS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN GASTRIC BANDS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN GASTRIC BANDS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN GASTRIC BANDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN GASTRIC BANDS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN GASTRIC BANDS MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 146. ASEAN GASTRIC BANDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. GCC GASTRIC BANDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. GCC GASTRIC BANDS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. GCC GASTRIC BANDS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. GCC GASTRIC BANDS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 151. GCC GASTRIC BANDS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 152. GCC GASTRIC BANDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 153. GCC GASTRIC BANDS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 154. GCC GASTRIC BANDS MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 155. GCC GASTRIC BANDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION GASTRIC BANDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION GASTRIC BANDS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION GASTRIC BANDS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPEAN UNION GASTRIC BANDS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION GASTRIC BANDS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION GASTRIC BANDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPEAN UNION GASTRIC BANDS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION GASTRIC BANDS MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION GASTRIC BANDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS GASTRIC BANDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS GASTRIC BANDS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. BRICS GASTRIC BANDS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS GASTRIC BANDS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS GASTRIC BANDS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 170. BRICS GASTRIC BANDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS GASTRIC BANDS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS GASTRIC BANDS MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 173. BRICS GASTRIC BANDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. G7 GASTRIC BANDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. G7 GASTRIC BANDS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. G7 GASTRIC BANDS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 177. G7 GASTRIC BANDS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 178. G7 GASTRIC BANDS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 179. G7 GASTRIC BANDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 180. G7 GASTRIC BANDS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 181. G7 GASTRIC BANDS MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 182. G7 GASTRIC BANDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. NATO GASTRIC BANDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. NATO GASTRIC BANDS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. NATO GASTRIC BANDS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 186. NATO GASTRIC BANDS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 187. NATO GASTRIC BANDS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 188. NATO GASTRIC BANDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 189. NATO GASTRIC BANDS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 190. NATO GASTRIC BANDS MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 191. NATO GASTRIC BANDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL GASTRIC BANDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES GASTRIC BANDS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES GASTRIC BANDS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. UNITED STATES GASTRIC BANDS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED STATES GASTRIC BANDS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES GASTRIC BANDS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 198. UNITED STATES GASTRIC BANDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED STATES GASTRIC BANDS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED STATES GASTRIC BANDS MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 201. UNITED STATES GASTRIC BANDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA GASTRIC BANDS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 203. CHINA GASTRIC BANDS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. CHINA GASTRIC BANDS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA GASTRIC BANDS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 206. CHINA GASTRIC BANDS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 207. CHINA GASTRIC BANDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 208. CHINA GASTRIC BANDS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 209. CHINA GASTRIC BANDS MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 210. CHINA GASTRIC BANDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)